Health Guardian runs quietly in the background 24/7, tracking health indicators that are normally invisible and providing monthly summaries in the Google Health app . It represents Google's most ambitious health-AI play for wearables to date, but the company is deliberately careful about what it claims the tool can and cannot do.

How Insulin Resistance Trends Works

Insulin Resistance Trends analyzes multi-week physiological data collected by sensors already inside the wearable: heart rate, heart rate variability (HRV), SpO₂, movement patterns, sleep quality, and skin temperature . That data feeds into AI models that detect shifts in metabolic health — specifically tracking whether insulin resistance is trending up or down .

The feature requires no blood draw, no glucose sensor, and no finger prick . Instead, it passively uses data the watch already collects .

Because metabolic changes happen slowly over long stretches, Google says Health Guardian needs approximately 30 days of continuous wear before delivering its first detailed summary . Users need a Fitbit Premium subscription to access the feature .

What It Does and Does Not Do

Google has been explicit about the tool's limitations:

• Does estimate trends in insulin resistance and flag meaningful changes that could indicate metabolic risk .
• Does not continuously monitor glucose levels .
• Does not produce a blood sugar number .
• Does not diagnose diabetes or pre-diabetes .

The company positions the feature as a wellness tool, not a medical diagnostic device .

Other Health Guardian Features

The suite includes three additional capabilities complementing insulin resistance tracking :

1. Blood Pressure Trends — Estimates blood pressure patterns over time without requiring a traditional cuff, using sensor data and machine learning .
2. Sleep Breathing Quality Trends — Tracks breathing patterns during sleep over extended periods to detect changes .
3. Breathing Emergency Detection — Can detect a serious respiratory event and automatically call emergency services if the user is unresponsive .

Availability, Devices, and Regulatory Status

• Devices: Pixel Watch 3, Pixel Watch 4, Pixel Watch 5, and Fitbit Air .
• Timing: Available as a software update starting September 2026 .
• Subscription: Requires Fitbit Premium .
• Regulatory: Not FDA-cleared. Explicitly positioned as a wellness tool, not a medical device .

The AI Model Behind It

Google says the AI model behind insulin resistance tracking was trained on more than one trillion minutes of sensor data from five million opted-in users . (Some sources describe the dataset as "millions of opted-in users across billions of minutes" .)

The underlying research, published in Nature on March 16, 2026, is titled "Insulin resistance prediction from wearables and routine blood biomarkers" . The study showed the multimodal model achieved:

• AUROC of 0.80
• Sensitivity of 76%
• Specificity of 84%

These results used wearable data plus demographic and blood biomarker data, validated against HOMA-IR — a clinical blood-test measure of insulin resistance . The clinical validation used data from the WEAR-ME study, which included over 1,100 participants .

Bottom Line

Google's Health Guardian is a significant step toward making metabolic health insights more accessible, but it is not a replacement for medical testing. The insulin resistance tracking feature offers a convenient, noninvasive way to spot long-term trends — enough to prompt a conversation with a doctor, but not enough to diagnose or monitor a condition on its own.

Health Guardian runs quietly in the background 24/7, tracking health indicators that are normally invisible and providing monthly summaries in the Google Health app . It represents Google's most ambitious health-AI play for wearables to date, but the company is deliberately careful about what it claims the tool can and cannot do.

How Insulin Resistance Trends Works

Insulin Resistance Trends analyzes multi-week physiological data collected by sensors already inside the wearable: heart rate, heart rate variability (HRV), SpO₂, movement patterns, sleep quality, and skin temperature . That data feeds into AI models that detect shifts in metabolic health — specifically tracking whether insulin resistance is trending up or down .

The feature requires no blood draw, no glucose sensor, and no finger prick . Instead, it passively uses data the watch already collects .

Because metabolic changes happen slowly over long stretches, Google says Health Guardian needs approximately 30 days of continuous wear before delivering its first detailed summary . Users need a Fitbit Premium subscription to access the feature .

What It Does and Does Not Do

Google has been explicit about the tool's limitations:

• Does estimate trends in insulin resistance and flag meaningful changes that could indicate metabolic risk .
• Does not continuously monitor glucose levels .
• Does not produce a blood sugar number .
• Does not diagnose diabetes or pre-diabetes .

The company positions the feature as a wellness tool, not a medical diagnostic device .

Other Health Guardian Features

The suite includes three additional capabilities complementing insulin resistance tracking :

1. Blood Pressure Trends — Estimates blood pressure patterns over time without requiring a traditional cuff, using sensor data and machine learning .
2. Sleep Breathing Quality Trends — Tracks breathing patterns during sleep over extended periods to detect changes .
3. Breathing Emergency Detection — Can detect a serious respiratory event and automatically call emergency services if the user is unresponsive .

Availability, Devices, and Regulatory Status

• Devices: Pixel Watch 3, Pixel Watch 4, Pixel Watch 5, and Fitbit Air .
• Timing: Available as a software update starting September 2026 .
• Subscription: Requires Fitbit Premium .
• Regulatory: Not FDA-cleared. Explicitly positioned as a wellness tool, not a medical device .

The AI Model Behind It

Google says the AI model behind insulin resistance tracking was trained on more than one trillion minutes of sensor data from five million opted-in users . (Some sources describe the dataset as "millions of opted-in users across billions of minutes" .)

The underlying research, published in Nature on March 16, 2026, is titled "Insulin resistance prediction from wearables and routine blood biomarkers" . The study showed the multimodal model achieved:

• AUROC of 0.80
• Sensitivity of 76%
• Specificity of 84%

These results used wearable data plus demographic and blood biomarker data, validated against HOMA-IR — a clinical blood-test measure of insulin resistance . The clinical validation used data from the WEAR-ME study, which included over 1,100 participants .

Bottom Line

Google's Health Guardian is a significant step toward making metabolic health insights more accessible, but it is not a replacement for medical testing. The insulin resistance tracking feature offers a convenient, noninvasive way to spot long-term trends — enough to prompt a conversation with a doctor, but not enough to diagnose or monitor a condition on its own.